Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank8
3Y CAGR-55.0%
5Y CAGR-46.9%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-55.0%/yr
vs +11.2%/yr prior
5Y CAGR
-46.9%/yr
Recent deceleration
Acceleration
-66.2pp
Decelerating
Percentile
P8
Near historical low
vs 5Y Ago
0x
Contraction
Streak
5 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $8.48M | -66.1% |
| 2024 | $25.03M | -3.1% |
| 2023 | $25.84M | -72.2% |
| 2022 | $92.94M | -12.4% |
| 2021 | $106.08M | -47.1% |
| 2020 | $200.40M | +169.7% |
| 2019 | $74.32M | +22.4% |
| 2018 | $60.70M | -23.4% |
| 2017 | $79.22M | +65.2% |
| 2016 | $47.97M | - |